Company intelligence / Profile preview

Neuronetrix

Louisville, Kentucky, United Statescognision.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

The COGNISION™ System has been validated in pilot studies with Alzheimer’s patients and healthy controls at the Sanders-Brown Alzheimer's Disease Center at University of Kentucky. It demonstrated high data quality and ease-of-use. The company planned a large multi-center study to further validate ERP biomarkers for cognitive impairment assessment. The system has been used globally in academic, clinical, pharmaceutical research—including by the US Army for blast injury evaluation—and supports both routine clinical use and drug development trials.

Therapeutic areas: OtherPsychiatryNeurology
Modalities: DeviceSoftware
Industry: Physiological Monitoring

Partnerships

Interest from large pharmaceutical companies for use in drug development trials

Beyond the preview

Go deeper on Neuronetrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronetrix.

Explore the full profile